Mark A. Rubin, director of the Institute for Precision Medicine, writes in Nature about the practicalities of realizing the potential of precision medicine. Read more
A team of researchers led by Giorgio Inghirami has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. Read more
Harold Varmus, M.D., pens a guest piece in the New York Daily News about the remarkable progress made in cancer research and the daunting road ahead. Read more
More than 70 bench scientists, oncologists and computational biologists from Weill Cornell Medical College will present their work at AACR's annual meeting this month. Read more
The American Association for Cancer Research (AACR) will honor Meyer director Lewis C. Cantley with the ninth annual Princess Takamatsu Memorial Lectureship at its annual meeting. Read more
Dean Laurie H. Glimcher, M.D., penned a guest piece for the Washington Post about the lasting impact of sharp cuts to federal funding for medical research. Read more
Mark A. Rubin, M.D., director of Weill Cornell's Institute for Precision Medicine, talks to Targeted Oncology about immunotherapy in the field of genitourinary cancers. Read more
Meyer Cancer Center director Lewis Cantley speaks to Cancer Therapy Advisor about progress in developing and testing effective PI3K pathway inhibitors. Read more
The Weill Cornell Breast Center and Tessa Cigler, M.D., are highlighted for their use of the innovative cold cap treatment to prevent hair loss during chemotherapy. Read more
A team of researchers led by Ethel Cesarman has sequenced the genome of Classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. Read more